2024 Participating Companies

It's the kind of meeting where biotech newsmakers can have productive dialogs with investors and other key players.

Luke Timmerman
The Timmerman Report
It's the caliber of attendees - biopharma companies on the verge of their next big step and investors looking for smart opportunities - that make BIO CEO & Investor Conference vital to the industry.

Anna Kazanchyan, MD
Founder & CEO, Saghmos Therapeutics
The BIO CEO & Investor Conference offers a collaborative forum where executives, investors and industry stakeholders can come together to learn and exchange ideas about innovation in the biopharma ecosystem.

Philip Ross, MD
Global Chairman, J.P. Morgan Healthcare Investment Banking
The BIO CEO & Investor Conference provides timely and relevant content on the issues driving the business of biotech, along with an invaluable platform for networking and partnering.

Chris Garabedian
Chairman and CEO, Xontogeny and Portfolio Manager, PXV Fund